eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.
eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
Company Details
- Employees
- 133
- Founded
- -
- Address
- 300 Technology Sq, Cambridge,ma 02139,united States
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- egenesisbio.com
- Keywords
- Genome Engineering.
- HQ
- Cambridge, MA
Egenesis, Inc. Questions
Egenesis, Inc.'s website is egenesisbio.com
Egenesis, Inc.'s LinkedIn profile is https://www.linkedin.com/company/egenesisbio
Egenesis, Inc. has
133 employees.
View email and phone details for 133
employees at Egenesis, Inc..
Egenesis, Inc.'s industry is
Biotechnology Research
Egenesis, Inc.'s top competitors are
Orsobio,
Colossal Biosciences,
Arsenal Biosciences, Inc.,
Mammoth Biosciences,
Beam Therapeutics,
Tessera Therapeutics,
Obsidian Therapeutics,
Dyno Therapeutics,
Editas Medicine,
Nimbus Therapeutics.
Egenesis, Inc.'s support email address is info@egenesisbio.com
Egenesis, Inc.'s categories are Biotechnology Research
Egenesis, Inc.'s founding year is 2015
